Stage III Colon Cancer Clinical Trials
38 clinical trials for Stage III Colon Cancer across international registries, including 4 currently recruiting participants. Compare status, phase, eligibility criteria and locations.
- Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease — RECRUITING · PHASE2
- French Assessment of MRD by Liquid Biopsies in Stage III CRC Patients (FRENCH.MRD.CRC) — RECRUITING
- Identification and Treatment Of Micrometastatic Disease in Stage III Colon Cancer — RECRUITING · PHASE3
- Phase II Open-label Trial of Neoadjuvant Immunochemotherapy for Resectable Non-metastatic Colon cancER: NICER — RECRUITING · PHASE2
- Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer — COMPLETED · PHASE3
- Exploiting Circulating Tumour DNA to Intensify the Postoperative Treatment Resected Colon Cancer Patients — SUSPENDED · PHASE2
- Oxaliplatin Adjuvant Chemotherapy After Curative Resection of Primary Colon Cancer — ACTIVE_NOT_RECRUITING
- LEAn Body Mass Normalization of OXaliplatin Based Chemotherapy — ACTIVE_NOT_RECRUITING · PHASE2
- Health Care Coach Support in Reducing Acute Care Use and Cost in Patients With Cancer — COMPLETED · NA
- Dasatinib for the Prevention of Oxaliplatin-Induced Neuropathy in Patients With Metastatic Gastrointestinal Cancer Receiving FOLFOX Chemotherapy With or Without Bevacizumab — COMPLETED · PHASE1
- Vaccine Therapy in Treating Patients With Colon, Pancreatic, or Lung Cancer — COMPLETED · PHASE1
- Encorafenib, Binimetinib, and Nivolumab in Treating Microsatellite Stable BRAF V600E Metastatic Colorectal Cancer — TERMINATED · PHASE1
- Avelumab Plus 5-FU Based Chemotherapy as Adjuvant Treatment for Stage 3 MSI-High or POLE Mutant Colon Cancer — TERMINATED · PHASE3
- Real-world Retrospective Data Analysis of Adjuvant Therapy for Patients With Stage II-III Colon Cancer After Radical Surgery — OTHER
- Exercise and Colon Cancer — COMPLETED · NA
- Immunotherapy With CEA(6D) VRP Vaccine (AVX701) in Patients With Stage III Colorectal Cancer — COMPLETED · PHASE1
- Prognostic Value of the Immunoscore® Colon Test for Disease Free Survival Stratification in Stage III Patients Under Oxaliplatin Treatment — OTHER
- Low Glycemic Load Diet in Patients With Stage I-III Colon Cancer — COMPLETED · NA
- Quality of Life and Survivorship Care in Patients Undergoing Hyperthermic Intraperitoneal Chemotherapy (HIPEC) — COMPLETED · NA
- Polyphenon E in Treating Patients With High-Risk of Colorectal Cancer — TERMINATED · PHASE2
- Vaccine Therapy in Treating Patients With Colorectal, Stomach, or Pancreatic Cancer — COMPLETED · PHASE1
- Maintenance Tegafur-uracil Versus Observation Following Adjuvant Oxaliplatin-based Regimen in Patients With Stage III Colon Cancer After Radical Resection — OTHER · NA
- Pertuzumab and Cetuximab in Treating Patients With Previously Treated Locally Advanced or Metastatic Colorectal Cancer — COMPLETED · PHASE1
- RO4929097 and Capecitabine in Treating Patients With Refractory Solid Tumors — COMPLETED · PHASE1
- Cytokine-induced Killer Cell Immunotherapy for Surgical Resected Stage III Colorectal Cancer Patients After Chemotherapy — OTHER · PHASE3
- Resveratrol in Treating Patients With Colorectal Cancer That Can Be Removed By Surgery — COMPLETED · PHASE1
- Erlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney, Colorectal, Head and Neck, Pancreatic, or Non-Small Cell Lung Cancer — COMPLETED · PHASE1
- Sorafenib, Cetuximab, and Irinotecan in Treating Patients With Advanced or Metastatic Colorectal Cancer — COMPLETED · PHASE1
- Combination Chemotherapy in Treating Patients With Stage III Colon Cancer — COMPLETED · PHASE3
- Suberoylanilide Hydroxamic Acid, Fluorouracil, Leucovorin, and Oxaliplatin in Treating Patients With Progressive Metastatic or Unresectable Colorectal Cancer or Other Solid Tumors — COMPLETED · PHASE1
- Alvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors — COMPLETED · PHASE1
- Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu — COMPLETED · PHASE1
- Combination Chemotherapy and Bevacizumab in Treating Patients With Locally Advanced, Metastatic, or Recurrent Colorectal Cancer — TERMINATED · PHASE3
- Vaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic Cancer — COMPLETED · PHASE1
- Combination Chemotherapy With or Without Bevacizumab Compared With Bevacizumab Alone in Treating Patients With Advanced or Metastatic Colorectal Cancer That Has Been Previously Treated — COMPLETED · PHASE3
- SU5416 and Irinotecan in Treating Patients With Advanced Colorectal Cancer — COMPLETED · PHASE1
- EF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung Cancer — TERMINATED · NA
- Fluorouracil Plus Leucovorin With or Without Oxaliplatin in Treating Patients With Stage II or Stage III Colon Cancer — COMPLETED · PHASE3
Refine this search